Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lestaurtinib with Chemotherapy in Relapsed FLT3-Mutated AML
NCT00079482Phase 2Completed
- Sponsor
- Cephalon, Inc.
- Start
- Oct 2003
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of lestaurtinib in acute myeloid leukemia (AML), sponsored by Cephalon, Inc.. Started Oct 2003; status: completed.
02
Drugs
lestaurtinib
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00079482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079482.